Deutsche Bank
NWBO

Deutsche Bank’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Deutsche Bank’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5
Closed – – 5338
2016
Q3 		$0 Sell
5
-426,406
-100% -$195K ﹤0.01% 5603
2016
Q2 		$247K Buy
426,411
+280,795
+193% +$300K ﹤0.01% 3658
2016
Q1 		$212K Buy
145,616
+129,957
+830% +$256K ﹤0.01% 3639
2015
Q4 		$49K Sell
15,659
-2,708
-15% -$13K ﹤0.01% 4416
2015
Q3 		$113K Buy
18,367
+7,119
+63% +$66.5K ﹤0.01% 4057
2015
Q2 		$111K Buy
11,248
+11,180
+16,441% +$97.9K ﹤0.01% 4188
2015
Q1 		$0 Buy
68
+44
+183% +$296 ﹤0.01% 6577
2014
Q4 		$0 Sell
24
-310
-93% -$1.59K ﹤0.01% 6632
2014
Q3 		$1K Buy
334
+160
+92% +$983 ﹤0.01% 5856
2014
Q2 		$1K Sell
174
-4,574
-96% -$29.1K ﹤0.01% 5854
2014
Q1 		$34K Buy
4,748
+4,482
+1,685% +$26.6K ﹤0.01% 4700
2013
Q4 		$1K Buy
+266
New +$1.03K ﹤0.01% 5361

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Deutsche Bank's NWBO Position: Q4 2016 in Review

Deutsche Bank sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 5 shares.

Deutsche Bank first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $247K in Q2 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Deutsche Bank reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Deutsche Bank sold 5 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016.
  • Deutsche Bank first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 12 quarters.
  • Deutsche Bank's Northwest Biotherapeutics, Inc. Common stock position peaked at $247K in Q2 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.